… growing PFA market. Dive Insight: Boston Scientific compared PFA with Farapulse to … message on the second-quarter earnings call. Martha framed the shift … “strong growth going forward.” Meanwhile, Boston Scientific has claimed leadership of the …

BOSTON SCIENTIFIC CORP (NYSE:BSX) was identified … has earned a 6: Explosive Earnings Growth BSX has shown positive … momentum in its earnings per share (EPS) on a … to generate sustained and positive earnings momentum. BSX has experienced 22 …

… out of 10: Explosive Earnings Growth With a favorable trend … quarter-to-quarter (Q2Q) earnings per share (EPS), BSX … s ability to generate positive earnings surprises and drive shareholder … like this It looks like BOSTON SCIENTIFIC CORP meets the Minervini …

… R&D have driven Boston Scientific's recent revenue and … fundamentals suggest that double-digit earnings growth can be sustained, there … a Hold at ~$97. magicmine Boston Scientific (NYSE:BSX) has shown high …

… Pulse Biosciences, Inc. beats earnings expectations. Reported EPS is $- … Biosciences’ Fourth Quarter 2024 Earnings Conference Call. All lines … Chief Operating Officer of Boston Scientific and committed 15 years … to review today’s earnings release for a detailed …

… TIVUS Intravascular Ultrasound System to Boston Scientific's interventional cardiology … of interventional cardiology therapies at Boston Scientific. "We believe the … dilutive to adjusted earnings per share in 2025, Boston Scientific plans to offset …

… of nearly 10% in SoniVie, Boston Scientific’s transaction includes an upfront … be slightly dilutive to Boston Scientific’s adjusted earnings per share (EPS) … THRIVE global IDE pivotal trial. Boston Scientific interventional cardiology therapies senior vice …

… struggling with high blood pressure. Boston Scientific, which already holds a … of interventional cardiology therapies at Boston Scientific. “We believe the addition … approvals. Boston Scientific anticipates a slight near-term dilution to earnings per share …

… weeks later. Marlborough, Massachusetts–based Boston Scientific is a strategic investor in … president of Interventional Cardiology Therapies, Boston Scientific. “We believe the addition of … slightly dilutive impact on adjusted earnings per share (EPS) in …

… disorders. With the acquisition, Boston Scientific will add SoniVie’s TIVUS … effect to adjusted earnings per share this year. Boston Scientific expects to counterbalance … research," Lance Bates, Boston Scientific senior vice president and president …